InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by SEIDENBERG BETH C, Director. Director active across 4 companies, notably Vera Therapeutics, Inc.. Cumulatively, 14 disclosures have been logged. The latest transaction was disclosed on 22 December 2021 — J. Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
019,265 shares0
Common Stock
SEC:0001179110-21-011241·
019,265 shares0
Common Stock
SEC:0001179110-21-011241:0·
0932,600 shares0
Common Stock
SEC:0001104659-21-141038·
0932,600 shares0
Common Stock
SEC:0001104659-21-141038:0·
032,802 shares0
Common Stock
SEC:0001179110-21-009627·
032,802 shares0
Common Stock
SEC:0001179110-21-009627:0·
029,494 shares0
Common Stock
SEC:0001179110-21-007597·
029,494 shares0
Common Stock
SEC:0001179110-21-007597:0·
084,964 shares0
Common Stock
SEC:0001179110-21-007016·
084,964 shares0
Common Stock
SEC:0001179110-21-007016:0·
011,000 shares0
Common Stock
SEC:0001140361-21-020447·
011,000 shares0
Common Stock
SEC:0001140361-21-020447:0·
423,642 shares
Class A Common Stock
SEC:0001209191-21-033810·
423,642 shares
Class A Common Stock
SEC:0001209191-21-033810:0·
14 of 14 declarations
About SEIDENBERG BETH C
Beth C. Seidenberg is a Board Member at Vera Therapeutics, Inc., Atara Biotherapeutics, Inc., and Progyny, Inc. She brings valuable experience in governance and strategic development. Her role on these boards is to oversee growth and innovation initiatives, ensuring that the companies achieve their long-term goals.
